These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18189148)

  • 1. Repeated enzyme immunoassays have limited utility in diagnosing Clostridium difficile.
    Drees M; Snydman DR; O'Sullivan CE
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):397-9. PubMed ID: 18189148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.
    Nemat H; Khan R; Ashraf MS; Matta M; Ahmed S; Edwards BT; Hussain R; Lesser M; Pekmezaris R; Dlugacz Y; Wolf-Klein G
    Am J Gastroenterol; 2009 Aug; 104(8):2035-41. PubMed ID: 19367273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea.
    Morelli MS; Rouster SD; Giannella RA; Sherman KE
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):669-74. PubMed ID: 15290659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of repeated stool toxin testing for diagnosing Clostridium difficile colitis.
    Gade R; Turett G
    South Med J; 2009 Oct; 102(10):1007-9. PubMed ID: 19738547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of repeat enzyme immunoassay testing for the diagnosis of Clostridium difficile infection: a systematic review of the literature.
    Garimella PS; Agarwal R; Katz A
    J Postgrad Med; 2012; 58(3):194-8. PubMed ID: 23023352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance between two enzyme immunoassays for the detection of Clostridium difficile toxins.
    Herrera-Cáceres JO; Camacho-Ortiz A; Galindo-Fraga A; Hernández-Durán M; Cordero-Rangel A; Hernández-Cruz A; Bobadilla-del Valle M; Ponce-de-León A; Sifuentes-Osornio J
    Arch Med Res; 2010 Feb; 41(2):92-6. PubMed ID: 20470937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey.
    Alcalá L; Marín M; Martín A; Sánchez-Somolinos M; Catalán P; Peláez MT; Bouza E;
    J Hosp Infect; 2011 Sep; 79(1):13-7. PubMed ID: 21741114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two enzyme immunoassays for detection of Clostridium difficile toxins A and B in swine.
    Anderson MA; Songer JG
    Vet Microbiol; 2008 Apr; 128(1-2):204-6. PubMed ID: 18006252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.
    Mattner F; Winterfeld I; Mattner L
    Scand J Infect Dis; 2012 Aug; 44(8):578-85. PubMed ID: 22404319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of repeat Clostridium difficile enzyme immunoassay testing.
    Cardona DM; Rand KH
    J Clin Microbiol; 2008 Nov; 46(11):3686-9. PubMed ID: 18845820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.
    Ramos Martínez A; Ortiz Balbuena J; Asensio Vegas Á; Sánchez Romero I; Múñez Rubio E; Cantero Caballero M; Cózar Llistó A; Portero Azorín F; Martínez Ruiz R
    Rev Esp Enferm Dig; 2016 Jun; 108(6):304-8. PubMed ID: 27033878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective assessment of two-stage testing for Clostridium difficile.
    Arnold A; Pope C; Bray S; Riley P; Breathnach A; Krishna S; Planche T
    J Hosp Infect; 2010 Sep; 76(1):18-22. PubMed ID: 20638749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile.
    Qutub MO; AlBaz N; Hawken P; Anoos A
    Indian J Med Microbiol; 2011; 29(3):293-6. PubMed ID: 21860113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies among three laboratory methods for Clostridium difficile detection and a proposal for their optimal use.
    Monteiro AA; Pires RN; Baethgen LF; Carneiro LC; Tavares RG; Caierão J; Park S; Perlin DS; Rodrigues Filho EM; Pasqualotto AC
    FEMS Microbiol Lett; 2014 Jan; 350(2):133-7. PubMed ID: 24236508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England.
    Goldenberg SD; French GL
    J Hosp Infect; 2011 Sep; 79(1):4-7. PubMed ID: 21724296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
    Chan EL; Seales D; Drum H
    Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new immunochromatography test for rapid and simultaneous detection of Clostridium difficile antigen and toxins.
    Samra Z; Madar-Shapiro L; Aziz M; Bishara J
    Isr Med Assoc J; 2013 Jul; 15(7):373-6. PubMed ID: 23943984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile testing algorithms: what is practical and feasible?
    Schmidt ML; Gilligan PH
    Anaerobe; 2009 Dec; 15(6):270-3. PubMed ID: 19853666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.